Matrix metalloproteinase-9 measured in urine from bladder cancer patients is an independent prognostic marker of poor survival

Author： Offersen Birgitte V.   Knap Marianne M.   Horsman Michael R.   Verheijen Jan   Hanemaaijer Roeland   Overgaard Jens  

Publisher： Informa Healthcare

ISSN： 0284-186X

Source： Acta Oncologica, Vol.49, Iss.8, 2010-11, pp. : 1283-1287

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Validation of Circulating MMP-7 Level as an Independent Prognostic Marker of Poor Survival in Urinary Bladder Cancer

By Szarvas Tibor  

Pathology & Oncology Research, Vol. 17, Iss. 2, 2011-06 ,pp. : 325-332

Springer Publishing Company

Access to resources Recommend Favorite

Serum Matrix-Metalloproteinase-1 is a Bona Fide Prognostic Marker for Colorectal Cancer

By Tahara Kouichirou  

Annals of Surgical Oncology, Vol. 17, Iss. 12, 2010-12 ,pp. : 3362-3369

Springer Publishing Company

Access to resources Recommend Favorite

Pretreatment levels of serum osteoprotegerin and p53 protein and urine telomerase as prognostic factors affecting survival in Egyptian bladder cancer patients

By        

Oncology Letters, Vol. 11, Iss. 1, 2016-01 ,pp. : 823-830

Spandidos Publications

Access to resources Recommend Favorite

Urine tenascinC is an independent risk factor for bladder cancer patients

By                    

Molecular Medicine Reports, Vol. 9, Iss. 3, 2014-01 ,pp. : 961-966

Spandidos Publications

Access to resources Recommend Favorite

Matrix metalloproteinase2 and 9 and tissue inhibitor of metalloproteinase1 and 2 in sera and urine of patients with renal carcinoma

By  

Oncology Letters, Vol. 7, Iss. 3, 2014-01 ,pp. : 621-626

Spandidos Publications

Access to resources Recommend Favorite